Press "Enter" to skip to content

World Bank Approves $ 12 Billion for Corona Vaccine and Treatment

The World Bank has approved $ 12 billion for coronavirus vaccines and treatment. (Symbolic picture)

The World Bank has approved an amount of $ 12 billion to help developing countries in the purchase, distribution, screening and treatment of Coronavirus Vaccine to help immunize one billion people. So to receive.

  • News18
  • Last Updated:October 14, 2020, 2:31 PM IST

Washington. The World Bank has approved an amount of $ 12 billion to help developing countries in buying, distributing, screening and treating the Coronavirus Vaccine to help immunize one billion people. So to receive. The World Bank said in a statement on Tuesday night that it is part of the World Bank Group’s $ 160 billion package to help developing countries deal with the Kovid-19 global epidemic.

‘Emergency action program reached 111 countries’

The World Bank said that Kovid-19 emergency action programs are already reaching 111 countries.
He said that citizens in developing countries also need access to safe and effective vaccines of Kovid-19.Also Read: US: Governor Candidate Accused, 36 Year Ago Girl Kidnapped And Now Murdered

Trump said at the rally, now I have disease resistant ability, I can come down and kiss anyone

World Bank President David Malpas said in a statement that we are expanding our approach to dealing with the Kovid-19 emergency to ensure fair and equal access to vaccines to developing countries.

Eli Lilly and Johnson & Johnson stop trial

US company Eli Lilly has banned the final phase of its major monoclonal antibody treatment for coronovirus. This ban has been imposed due to possible security concerns. Eli Lilly Company has confirmed this. Company spokeswoman Molly McCulli said that safety is of paramount importance to Lily. We are aware that, due to extreme caution, the ACTIV-3 Independent Data Security Monitoring Board (DSMB) has recommended to prevent it from enrollment. At the same time, Dr. Mathai Maiman, Global Head of Johnson Research and Development arm, said in the conference call that the company has very little information and we are currently stopping trials of a participant getting sick during a trial.

.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *